|

Pharmacogenetic Supported Prescribing in Kids

RECRUITINGN/ASponsored by University of Calgary
Actively Recruiting
PhaseN/A
SponsorUniversity of Calgary
Started2021-01-18
Est. completion2025-07-01
Eligibility
Age6 Years – 24 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04797364

Summary

Implementation of pharmacogenetic testing for children and adolescents aged 6-24 who are starting or changing psychiatric medication.

Eligibility

Age: 6 Years – 24 YearsHealthy volunteers accepted
Inclusion Criteria:

* Medical records available
* The initiation, change, dose adjustment, or augmentation of psychiatric medication(s) is indicated
* Treating psychiatrist, family physician, or pediatrician licensed in Alberta, British Columbia, Saskatchewan, or Manitoba requests pharmacogenetic testing

Exclusion Criteria:

* Medically unstable or lacking capacity to provided informed consent
* Unwillingness of child to provide saliva sample for genetic analysis
* History of liver or bone marrow (hematopoietic cell) transplant

Conditions3

AnxietyDepressionMental Health Impairment

Browse More Trials

Depression trialsAnxiety trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.